Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 6,371,669 | 6,371,669 | 0 | $452.71M | $451.69M | 65.93% | -$1.02M |
| Nuvation Bio Inc.(NUVB) | 25,954,439 | 25,954,439 | 0 | $147.42M | $145.34M | 21.22% | -$2.08M |
| Aclaris Therapeutics, Inc. | 4,041,736 | 4,041,736 | 0 | $21.38M | $21.26M | 3.10% | -$121.3K |
| Aardvark Therapeutics Inc | 3,917,299 | 3,917,299 | 0 | $22.56M | $20.64M | 3.01% | -$1.92M |
| Upstream Bio Inc. | 2,724,868 | 2,724,868 | 0 | $18.86M | $14.36M | 2.10% | -$4.50M |
| Arcus Biosciences, Inc.(RCUS) | 464,779 | 425,079 | -39,700 | $14.33M | $10.98M | 1.60% | -$3.35M |
| Equillium Inc. | 4,447,308 | 4,447,308 | 0 | $14.23M | $7.23M | 1.05% | -$7.00M |
| Lyell Immunopharma, Inc. | 692,050 | 692,050 | 0 | $9.72M | $6.78M | 0.99% | -$2.95M |
| Zentalis Pharmaceuticals Inc. | 1,323,327 | 1,323,327 | 0 | $6.42M | $3.67M | 0.54% | -$2.75M |
| BeyondSpring Inc.SHS | 3,800,702 | 3,065,702 | -735,000 | $6.65M | $2.36M | 0.34% | -$4.29M |
| Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | 326,810 | 0 | $983.7K | $761.5K | 0.11% | -$222.2K |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 176,887 | 0 | -176,887 | $5.99M | $0 | — | -$5.99M |
| Revolution Medicines, Inc.(RVMD) | 52,667 | 0 | -52,667 | $9.86M | $0 | — | -$9.86M |
| Tango Therapeutics, Inc.(TNGX) | 20,000 | 0 | -20,000 | $625.2K | $0 | — | -$625.2K |